Jarrod D. Longcor

Insider Reports History

Identity
Location
New Haven, CT
SEC record
Reporting signature
/s/ Christina Blakley, attorney-in-fact for Jarrod D. Longcor
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Jarrod D. Longcor:

Form 4 holding Chief Operating Officer

Cellectar Biosciences, Inc.

Security class
Stock option (right to buy)
Shares / value
500,000
Estimated value
Report date
14 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jarrod D. Longcor

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .